-
EP3829607
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3829607
| EP3829607 - CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.03.2023 Database last updated on 03.09.2024 | |
| Former | Request for examination was made Status updated on 07.05.2021 | ||
| Former | The international publication has been made Status updated on 08.02.2020 | Most recent event Tooltip | 31.03.2023 | Application deemed to be withdrawn | published on 03.05.2023 [2023/18] | Applicant(s) | For all designated states Histogen, Inc. 10655 Sorrento Valley Road San Diego, CA 92121 / US | [2021/23] | Inventor(s) | 01 /
NAUGHTON, Gail, K. c/o Histogen, Inc. 10655 Sorrento Valley Road San Diego, CA 92121 / US | [2021/23] | Representative(s) | Kilburn & Strode LLP Lacon London 84 Theobalds Road Holborn London WC1X 8NL / GB | [N/P] |
| Former [2021/23] | Cornish, Kristina Victoria Joy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | Application number, filing date | 19845189.0 | 31.07.2019 | [2021/23] | WO2019US44405 | Priority number, date | US201862713984P | 02.08.2018 Original published format: US 201862713984 P | [2021/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020028526 | Date: | 06.02.2020 | Language: | EN | [2020/06] | Type: | A1 Application with search report | No.: | EP3829607 | Date: | 09.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.02.2020 takes the place of the publication of the European patent application. | [2021/23] | Search report(s) | International search report - published on: | US | 06.02.2020 | (Supplementary) European search report - dispatched on: | EP | 29.04.2022 | Classification | IPC: | A61K35/33, A61K35/00, A61K35/12, A61Q7/00, C07K14/78, C12N5/077 | [2022/22] | CPC: |
A61P17/14 (EP);
A61K8/981 (US);
A61K35/33 (EP);
A61K8/046 (US);
A61K8/42 (US);
A61K8/4953 (EP,US);
A61K8/64 (EP,US);
A61K8/99 (EP);
A61P17/00 (EP);
A61Q3/00 (EP,US);
A61Q7/00 (EP,US);
C07K14/78 (EP);
C12N5/0652 (US);
C12N5/0656 (EP);
C12N2500/02 (EP,US);
C12N2511/00 (US);
C12N2513/00 (EP);
C12N2531/00 (EP);
C12N2533/90 (EP)
(-)
|
| Former IPC [2021/23] | A61K35/33, A61K35/00, A61K35/12, A61Q7/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/23] | Title | German: | KONDITIONIERTES MEDIUM UND EXTRAZELLULÄRE MATRIXZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN | [2021/23] | English: | CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS AND USES THEREOF | [2021/23] | French: | COMPOSITIONS DE MILIEU CONDITIONNÉ ET DE MATRICE EXTRACELLULAIRE, ET UTILISATIONS DE CELLES-CI | [2021/23] | Entry into regional phase | 01.03.2021 | National basic fee paid | 01.03.2021 | Search fee paid | 01.03.2021 | Designation fee(s) paid | 01.03.2021 | Examination fee paid | Examination procedure | 01.03.2021 | Examination requested [2021/23] | 15.09.2021 | Amendment by applicant (claims and/or description) | 29.11.2022 | Application deemed to be withdrawn, date of legal effect [2023/18] | 20.12.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/18] | Fees paid | Renewal fee | 13.08.2021 | Renewal fee patent year 03 | 21.07.2022 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2021 | 03 M06 Fee paid on 13.08.2021 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US4596812 (CHIDSEY III CHARLES A [US], et al) [A] 5-7,13 * the whole document *; | [A]US2003147823 (WOODWARD DAVID F [US], et al) [A] 8,9,14 * the whole document *; | [X]WO2010056378 (HISTOGEN INC [US], et al) [X] 1-3,10-12,15,16 * claim 1; paragraphs 60, 62, 68, 149, 168 *; | [X]WO2011006107 (HISTOGEN INC [US], et al) [X] 1-3,10-12,15,16 * abstract; claim 1 and 43; paragraphs 1, 31, 73, 75, 81 *; | [A]WO2012106249 (ALLERGAN INC [US], et al) [A] 5-9,13,14* the whole document *; | [XI]US2012225029 (AL-QAHTANI AHMED H [US]) [X] 1,3-5,7,10,12,13,15,16 * claims 1, 24, 28; paragraphs 8, 22, 117; figures 11-13 * [I] 6,8,9,14; | [X]WO2016176620 (HISTOGEN INC [US]) [X] 1-3,10-12,15,16 * paragraphs 63 ff., 75, 77, 83, 164, 203 *; | [X] - KELLAR ET AL., "Tissue-engineered human embryonic-like conditioned media for therapeutic applications ED - Lim Henry W", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY, INC, US, vol. 60, no. 3, doi:10.1016/J.JAAD.2008.11.859, ISSN 0190-9622, (20090301), page AB198, (20090224), XP025964666 [X] 1-4,12,15,16 * abstract * DOI: http://dx.doi.org/10.1016/j.jaad.2008.11.859 | [X] - ZEIGLER AND NAUGHTON, "Commercial-scale production of wnts for inducing hair follicle growth and neogenesis as a treatment for alopecias", JOURNAL OF DERMATOLOGICAL SCIENCE, ELSEVIER, AMSTERDAM, NL, Abstracts for the International Investigative Dermatology 2008, (20080401), vol. 50, no. 2, ISSN 0923-1811, pages e150 - e150, XP022575973 [X] 1-4,12,15,16 * Abstract 889, p e150 * | International search | [A]US5130142 (WONG TERESA K [US], et al) [A] 1-5, 27, 42-46 * entire document *; | [A]US2007036742 (ROUFS JAMES B [US], et al) [A] 1-5, 27, 42-46* entire document *; | [X]US2010047305 (NAUGHTON GAIL K [US], et al) [X] 1-5, 27, 42-46 * entire document * |